GSK

News

GSK et al win another round in Zantac cancer litigation

GSK and other drugmakers fending off litigation claiming that gastrointestinal drug Zantac or a generic caused cancer have won a supreme court ruling in Canada, after also

News

Caution urged as Pfizer’s maternal RSV shot adcomm nears

There have been calls for caution when it comes to the use of Pfizer’s respiratory syncytial virus (RSV) vaccine in pregnant women, ahead of an FDA advisory committee meet

News

GSK claims first global approval for an RSV vaccine

GSK has become the first pharma company to get regulatory approval for a vaccine against respiratory syncytial virus (RSV), setting up what looks set to be a highly lucrat

R&D

The race for gold: Closing in on the first RSV vaccine

The industry looks set to bring the first vaccine for RSV to market in the coming year. But, which companies are leading the race, and why it would mark an important development for global health?

News

Wave of strikes hit GSK’s UK manufacturing

GSK was able to avert industrial action at some of its UK facilities last year after agreeing a

News

GSK’s RSV vaccine in EU pole position after CHMP backing

GSK looks set to bring the first vaccine for respiratory syncytial virus (RSV) to market in the EU, after its Arexvy shot was recommended for approval by the EMA’s human m

GSK et al win another round in Zantac cancer litigation

Caution urged as Pfizer’s maternal RSV shot adcomm nears

GSK claims first global approval for an RSV vaccine

The race for gold: Closing in on the first RSV vaccine

Wave of strikes hit GSK’s UK manufacturing

GSK’s RSV vaccine in EU pole position after CHMP backing

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

GSK

Editor's Picks